Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)
Clinical trial NCT02105467 · COMPLETED
Trial details
- NCT number
- NCT02105467
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-05
- Primary completion
- 2015-02-26
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.